Tenofovir (TDF) containing first-line HAART is associated with changes in plasma parameters suggestive of increased bone resorption

Tenofovir (TDF) containing first-line HAART is associated with changes in plasma parameters suggestive of increased bone resorption

Bibliographic Details
Main Authors:	Blanco Francisco, Fernandez Jose, Vispo Eugenia, Medrano Jose, Sanchez Carlos A, Barreio Pablo, Labarga Pablo, Gonzalez-Lahoz Juan, Soriano Vicente
Format:	Article
Language:	English
Published:	BMC 2010-05-01
Series:	Retrovirology

Similar Items

Early switching of tenofovir disoproxil fumarate (TDF) in HIV-infected patients with TDF-induced nephrotoxicity: a prospective study
by: Samadhi Patamatamkul, et al.
Published: (2022-12-01)

Lipid profile after switching from TDF (tenofovir disoproxil)-containing to TAF (tenofovir alafenamide)-containing regimen in virologically suppressed people living with HIV
by: Michał Łomiak, et al.
Published: (2023-09-01)

The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile
by: Squillace N, et al.
Published: (2020-12-01)

Glomerular filtration (GF) determined by creatinine clearance (CCR) in 24 hours urine and cockcroft & gault (cg) and modification of diet in renal disease (MDRD) equations in a large cohort of HIV+ patients
by: Vispo Eugenia, et al.
Published: (2010-05-01)

HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study
by: Marianne Harris, et al.
Published: (2017-11-01)

Formulation development and optimization of Lamivudine 300 mg and Tenofovir Disoproxil Fumarate (TDF) 300 mg FDC tablets by D-optimal mixture design
by: Prosper Tibalinda, et al.
Published: (2016-12-01)

Use of Territorial Defense Forces (TDF) in combat operations
by: Marek Pytel, et al.
Published: (2021-03-01)

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
by: Tingyan Wang, et al.
Published: (2021-06-01)

TDF: A compact file format plugin for FEniCS
by: Anthony Dowling, et al.
Published: (2023-05-01)

Use of the Territorial Defence Forces (TDF) in counter-subversive operations
by: Marek Pytel, et al.
Published: (2020-06-01)

Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter study
by: Hariklia Kranidioti, et al.
Published: (2024-04-01)

Hypophosphataemia with non-tenofovir-containing antiretroviral therapy.
by: Wainwright, E, et al.
Published: (2013)

Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial
by: Adrian Curran, et al.
Published: (2020-04-01)

Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV
by: Paula Munderi, et al.
Published: (2019-07-01)

Virologically suppressed HIV-infected patients on TDF-containing regimens significantly benefit from switching to TAF-containing regimens: A meta-analysis of randomized controlled trials
by: Xingbao Tao, et al.
Published: (2019-10-01)

Neurodegeneration in the HAART era
by: Brew Bruce J
Published: (2010-05-01)

The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis
by: Zeyu Zhang, et al.
Published: (2019-05-01)

Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study.
by: Win Min Han, et al.
Published: (2020-01-01)

A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate versus Tenofovir Alafenamide
by: Chanie Wassner PharmD, BCCCP, BCIDP, et al.
Published: (2020-04-01)

Analysis of Combustion Characteristics of Waste Plastic Disposal Fuel (WPDF) and Tire Derived Fuel (TDF)
by: Abdul Adam, Abdullah, et al.
Published: (2015)

Content of TDF, SDF and IDF in Cereals Grown by Organic and Conventional Farming – a Short Report
by: Menkovska Mirjana, et al.
Published: (2017-09-01)

Analisis Kekuatan Rangka Pada Mesin Transverse Ducting Flange (TDF) Menggunakan Software Solidworks
by: Eko Prasetyo, et al.
Published: (2020-12-01)

Current use of statins reduces risk of HIV rebound on suppressive HAART.
by: Henning Drechsler, et al.
Published: (2017-01-01)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
by: Aida N. Kawuma, et al.
Published: (2023-06-01)

HAART and the liver: friend or foe?
by: Pineda JA, et al.
Published: (2010-03-01)

Chemoprophylaxis and HAART Therapy in Botswana
by: Essex M
Published: (2005-12-01)

Hypophosphataemia in HIV-positive patients taking non-tenofovir-containing antiretrovirals
by: Wainwright, E, et al.
Published: (2011)

Fabrication of PEGylated Chitosan Nanoparticles Containing Tenofovir Alafenamide: Synthesis and Characterization
by: Muhammad Zaman, et al.
Published: (2022-12-01)

Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort
by: Chua Arlene C, et al.
Published: (2012-06-01)

Development and evaluation of mucoadhesive bigel containing tenofovir and maraviroc for HIV prophylaxis
by: Margaret O. Ilomuanya, et al.
Published: (2020-11-01)

Changes in the adipocyte (lipid and glucose metabolism) gene expression following 18-24 months treatment with ZDV or TDF-containing ART; and adipocyte mitochondrial gene expression
by: Gathercole, L, et al.
Published: (2009)

Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings.
by: Andrea Ries Thurman, et al.
Published: (2019-01-01)

TDF and TAF inhibit liver cancer cell migration, invasion via p7TP3
by: Jing Zhao, et al.
Published: (2024-04-01)

Tolerance and viral resistance after single-dose nevirapine (NVP) and short-course of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) to prevent mother-to-child transmission (PMTCT) of HIV-1: the TEmAA ANRS 12109 phase II trial, step 1
by: Ekouévi Didier, et al.
Published: (2008-04-01)

Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort
by: Bernard Surial, et al.
Published: (2019-10-01)

Tenofovir-Containing Antiretroviral Therapy and Clinical Outcomes of SARS-CoV-2 Infection in People Living with HIV
by: María F. Rombini, et al.
Published: (2023-05-01)

Demonstration project of oral TDF-containing PrEP, administered, once-daily orally to men having sex with men (MSM) and transgender women (TGW) in India: Study protocol.
by: Seema Sahay, et al.
Published: (2023-01-01)

Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
by: Tim R. Cressey, et al.
Published: (2020-08-01)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
by: Sinha Rajesh, et al.
Published: (2008-01-01)

Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates.
by: Xinhui Chen, et al.
Published: (2016-01-01)